In2it, Even if there were grounds for a class action lawsuit, the company doesn't have any money for the 'winners' and their lawyers to collect. The lawyers would take any remaining proceeds.
Instead of being bitter, you guys should have just kept Cortex in the 'entertainment only' bin, instead of allowing it to become the centerpiece of a portfolio. That's where most bio stocks belong anyway, the entertainment bin.
News 
Market Data 
Discover 
AI
